Skip to content

Absci Corporation ABSI Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Schrodinger logo
SchrodingerSDGR
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
Precigen logo
PrecigenPGEN
BridgeBio Pharma logo
BridgeBio PharmaBBIO

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's deferred tax assets and other non-current assets?
Absci Corporation (ABSI) reported deferred tax assets and other non-current assets of $383K in Q1 2026.
How has Absci Corporation's deferred tax assets and other non-current assets changed year-over-year?
Absci Corporation's deferred tax assets and other non-current assets decreased by 39.3% year-over-year, from $631K to $383K.
What is the long-term trend for Absci Corporation's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Absci Corporation's deferred tax assets and other non-current assets has grown at a 28.6% compound annual growth rate (CAGR), from $109K to $383K.